Humpath.com - Human pathology

Home > G. Tumoral pathology > Molecular pathology of tumors > Liquid biopsy > monitoring of acquired RAS-mediated resistance to cetuximab

monitoring of acquired RAS-mediated resistance to cetuximab

Friday 29 April 2016

Open references

- Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma. Braig F, Voigtlaender M, Schieferdecker A, Busch CJ, Laban S, Grob T, Kriegs M, Knecht R, Bokemeyer C, Binder M. Oncotarget. 2016 Apr 22. doi : 10.18632/oncotarget.8943 PMID: 27119512 (Free)